Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Stable Mortality Rates Despite Rising Incidence of Melanoma
1
Mins
May 2024
Mortality rates of Melanoma have remained stable despite rising incidence, with reasons for this disparity still unclear.
Read more
7
Mins
18th March 2016
STELARA® Induced Clinical Response and Remission in Phase 3 Study for the Treatment of Patients with Moderate to Severe Crohn’s Disease Who Had Previously Failed or Were Intolerant to Anti-TNF-Alpha Therapy
STELARA® Induced Clinical Response and Remission in Phase 3 Study for the Treatment of Patients with Moderate to Severe Crohn’s Disease Who Had Previously Failed or Were Intolerant to Anti-TNF-Alpha Therapy
3
Mins
23rd February 2016
First Patients Enrolled and Dosed in the Pivotal Trial of Phase 3 of the Immunotherapy Tedopi® for Advanced Non-Small Cell Lung Cancer
Paris, February 22nd, 2016, 6:30pm – OSE Pharma SA (ISIN: FR0012127173; Mnémo: OSE), an immunooncology company with a specific immunotherapy…
1
Mins
19th February 2016
Introducing the European Medical Journal 1.1
United Kingdom, February 19, 2016: The first edition of the European Medical Journal is available now, this is the first of four issues new for 2016.
2
Mins
10th February 2016
Smoking and Inactivity Lead to Alarming Rise in Heart Attacks among Young Indians
Chennai, India 10 February 2016: An increase in smoking and physical inactivity in young adults in India has led to an alarming rise in heart attacks…
1
Mins
16th December 2015
ESMO Asia 2015 Congress
LUGANO/SINGAPORE, 16 December 2015 – ESMO, the leading professional organisation for medical oncology, is pleased to announce the inaugural ESMO Asia…
4
Mins
15th December 2015
New SEER Registry “Big Data” Demonstrates the Oncotype DX® Test Accurately Predicts Clinical Breast Cancer Outcomes, Bringing the Total Number of Patients in Prospective Outcome Studies to 50,000
GENEVA, Switzerland, [December 14, 2015] – Genomic Health today announced results from multiple Oncotype DX® breast cancer test studies at the…
1
Mins
24th November 2015
SCHILLER Enables the Export of ECG Raw Data: Resting ECGs, Exercise ECGs and Resting Rhythms
SCHILLER’s declared goal is to make therapy-relevant data accessible in digital form throughout the hospital. Thanks to the latest development, we have…
1
Mins
16th November 2015
Revolutionary Computer Program Diagnoses Cancer in 2 Days
NOVEL diagnostic technology based on advanced self-learning computer algorithms may identify the source of cancer in a patient with 85% certainty…
Loading posts...
« Previous
1
…
23
24
25
26
27
…
29
Next »